Lucy Scientific Discovery Announces Partnership with High Times® to Develop and Distribute a New Line of Psychoactive Products

Rhea-AI Summary

Lucy Scientific Discovery Inc. (NASDAQ:LSDI) has announced the launch of a new line of psychoactive products called 'Mindful by Lucy', featuring Amanita Muscaria mushrooms. This product is designed to cater to the growing market for psychoactive alternatives, projected to exceed $5 billion by 2025. The company has partnered with High Times to leverage their extensive reach through websites and social media, targeting an initial launch in Q2 2023. Lucy received $2.5 million in advertising credits as part of a strategic investment agreement with High Times. CEO Chris McElvany emphasized the potential health benefits of adaptogens in addressing conditions like PTSD and anxiety.

Positive

• Launch of 'Mindful by Lucy' product line featuring Amanita Muscaria mushrooms targets growing psychoactive market.
• Strategic partnership with High Times to utilize their audience of over 10 million for marketing efforts.
• Projected market for psychoactive alternatives expected to exceed $5 billion by 2025.
• $2.5 million received in advertising credits to support product launch.

Negative

• None.

VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (“Lucy” or “The Company”) [NASDAQ:LSDI], a leading NASDAQ-listed psychedelic drug manufacturer, announced today the launch of a new line of unscheduled psychoactive compounds that will be available for sale throughout the United States, and where permitted throughout the rest of the world.

The first line in the new family of brands contains Amanita Muscaria mushrooms, a psychoactive adaptogen. The product leverages the compounds of these mushrooms, and a proprietary blend of other natural functional ingredients, to create a transformative experience for consumers worldwide. This product line is named ‘Mindful by Lucy’.

Lucy Scientific will produce Mindful with High Times, through a strategic partnership with Hightimes Holding Corp., the parent company of High Times®, the most well-known brand in cannabis. This collaboration aims to distribute and market the products initially through High Times' websites and social channels which reach over 10 million people across their owned and operated properties and social media accounts.

With a product launch targeted for Q2 2023, this new line is well-positioned to capitalize on the growing market for psychoactive alternatives, which Forbes predicts will double to over $5 billion in gross sales by 2025.

Lucy and High Times entered into a strategic investment agreement in January whereby Lucy received $2.5 million in advertising credits that will help launch the new brand into market through High Times channels and experiential events.

Chris McElvany, Chief Executive Officer of Lucy Scientific Discovery Inc., stated, “As awareness and acceptance of alternative treatments for various conditions, such as PTSD, anxiety disorders, and depression, continue to grow, adaptogens are emerging as a leading therapeutic remedy. This partnership between Lucy and High Times will enable the two companies to expand the reach of Lucy’s products and promote the potential health benefits to a broader audience.”

About Lucy Scientific Discovery Inc.
Lucy Scientific Discovery Inc. is a Nasdaq-listed [NASDAQ:LSDI] licensed producer of compounds for medicinal products. As granted by Health Canada’s Office of Controlled Substances, Lucy maintains a Controlled Drugs and Substances Dealer’s License, held by its wholly owned subsidiary LSDI Manufacturing Inc. under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), or a Dealer’s License. A Dealer’s License authorizes LSDI to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.

About High Times
For nearly five decades, High Times has been the foremost cannabis brand, promoting the lifestyle and educating the public on the benefits of this natural flower. Starting as a counterculture lifestyle publication, High Times has evolved into a rapidly expanding network of cannabis dispensaries, the creator of industry-leading events such as the Cannabis Cup, a producer of globally distributed merchandise, a beneficiary of international licensing deals, and a content provider for millions of fans and supporters worldwide. In the cannabis industry, High Times is the most trusted authority on quality.

Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements. Forward-looking statements give our current expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. Forward-looking statements involve risks and uncertainties and include statements regarding, among other things, our projected revenue growth and profitability, our growth strategies and opportunity, anticipated trends in our market and our anticipated needs for working capital. They are generally identifiable by use of the words "may," "will," "should," "anticipate," "estimate," "plans," "potential," "projects," "continuing," "ongoing," "expects," "management believes," "we believe," "we intend" or the negative of these words or other variations on these words or comparable terminology. In particular, these include statements relating to future actions, prospective products, market acceptance, future performance, results of current and anticipated products, sales efforts, expenses, and the outcome.

These statements are based on our management's expectations, beliefs and assumptions concerning future events affecting us, which in turn are based on currently available information. These assumptions could prove inaccurate. Although we believe that the estimates and projections reflected in the forward-looking statements are reasonable, our expectations may prove to be incorrect.

Media Contact:
Lucas Wentworth
Lucas@NisonCo.com
NisonCo Public Relations

Investor Contact: 
Addo Investor Relations, Inc.
lucyscientific@addo.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/bfc359db-1d1a-45f0-8b87-fb7853decc72

FAQ

What is the new product line launched by Lucy Scientific Discovery Inc.?

The new product line is called 'Mindful by Lucy', featuring Amanita Muscaria mushrooms.

When is the launch date for the 'Mindful by Lucy' product line?

The product line is targeted for launch in Q2 2023.

What partnership has Lucy Scientific entered into for marketing their new product?

Lucy Scientific has partnered with High Times for marketing and distribution of the new product line.

What is the expected market size for psychoactive alternatives by 2025?

The market for psychoactive alternatives is projected to exceed $5 billion by 2025.

How much in advertising credits did Lucy receive from High Times?

Lucy received $2.5 million in advertising credits from High Times.